USPTO 2015–2025 USPTO PatentsView US Corporation

Megadyne Medical Products, Inc.

USPTO PatentsView assignee record - 46 granted patents across 14 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Megadyne ranks #7,162 of 49,997 tracked US assignees by granted-patent volume, with 46 patents across 14 technology areas.

#7,162
of 49,997 US assignees by volume
Top 31%
by Innovation Score (42.1/100)
17.6
avg claims per patent
+107%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7162 · US Corporation #7,162 · 46 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 46 grants
  • UPPER-Q #7,162/49,997
  • PHOTO-FINISH Kyowa Kirin
  • CPC-FOCUS A61B · 14 areas
  • INNOV-PAR 42.1/100
  • CLAIMS-RICH 17.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +107% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Kyowa Kirin Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Megadyne’s 42.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Megadyne

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Megadyne's Innovation Score is 42.1/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Megadyne?

Each dot is one of Megadyne’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Megadyne’s own 17.6 claims/patent is ABOVE the 13.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Megadyne vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 45.946.046.04646.046.046.1 0510152025 Granted patents (volume) Avg claims / patent Kyowa Kirin Co., Ltd. - 46, 13.59Kyowa KirinLiebherr-aerospace Toulouse SAS - 46, 11.33Liebherr-aerospac…Lagom Kitchen Co. - 46, 2.78Lagom KitchenLos Angeles BioMedical Research Institute at Harbor Ucla Medical Center - 46, 16.87Los Angeles Biome…Mutualink, Inc. - 46, 22.52MutualinkMarquette University - 46, 17.13Marquette Univers…Menasha Corporation - 46, 16.57MenashaMustang Sampling, LLC - 46, 11Mustang SamplingMegadyne Medical Products, Inc. - 46, 17.65Megadyne Medical…
Megadyne vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Megadyne's grants concentrate

Megadyne Medical Products, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 78.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (9 grants) versus a trough of 2 in 2018. By volume, Megadyne sits between Kyowa Kirin Co., Ltd. and Mustang Sampling, LLC.

Megadyne's three-year grant acceleration

From 2019–2021 to 2022–2024, Megadyne Medical Products, Inc. moved from 20 to 15 grants (0.75x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Megadyne's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Megadyne holds 46 patents at rank #7,160, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Megadyne

By rank, the assignees closest to #7,160 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Megadyne's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Megadyne, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Megadyne ranks #527 of 7,127 assignees by patent count in that subclass.

Megadyne's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 2015201620182019202020212022202320242025 3
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Megadyne Medical Products, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 6.5%
2016 3 6.5%
2018 2 4.3%
2019 6 13.0%
2020 7 15.2%
2021 7 15.2%
2022 9 19.6%
2023 2 4.3%
2024 4 8.7%
2025partial year 3 6.5%

Which technologies does Megadyne Medical Products, Inc. patent most?

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Megadyne Medical Products, Inc.'s patent record in context - here's where to go next.

  • Megadyne Medical Products, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 78.3% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #7,162 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Megadyne Medical Products, Inc. against Kyowa Kirin Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 42.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.